ICL vs. CLBT
ICL (ICL Group Ltd) and CLBT (Cellebrite DI Ltd.) are both stocks. ICL operates in Agricultural Inputs (Basic Materials), while CLBT operates in Software - Infrastructure (Technology). Over the past 3 years, ICL returned 3.81%/yr vs 29.74%/yr for CLBT. At a 0.18 correlation, their price movements are largely independent.
Performance
ICL vs. CLBT - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, ICL achieves a -0.43% return, which is significantly higher than CLBT's -25.51% return.
ICL
- 1D
- -0.18%
- 1M
- -11.52%
- YTD
- -0.43%
- 6M
- 11.48%
- 1Y
- -13.76%
- 3Y*
- 3.81%
- 5Y*
- 0.16%
- 10Y*
- 9.01%
CLBT
- 1D
- -2.75%
- 1M
- -1.40%
- YTD
- -25.51%
- 6M
- -25.80%
- 1Y
- -18.75%
- 3Y*
- 29.74%
- 5Y*
- —
- 10Y*
- —
ICL vs. CLBT - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
ICL ICL Group Ltd | -0.43% | 18.12% | 2.81% | -27.23% | -14.74% | 37.49% |
CLBT Cellebrite DI Ltd. | -25.51% | -18.16% | 154.39% | 98.62% | -45.64% | -21.76% |
Correlation
The correlation between ICL and CLBT is 0.15, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.15 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.24 |
Correlation (All Time) Calculated using the full available price history since Sep 1, 2021 | 0.18 |
Fundamentals
ICL:
$7.21B
CLBT:
$3.39B
ICL:
$0.20
CLBT:
$0.29
ICL:
27.66
CLBT:
46.83
ICL:
20.23
CLBT:
0.09
ICL:
0.97
CLBT:
6.78
ICL:
1.19
CLBT:
6.63
ICL:
$7.41B
CLBT:
$496.43M
ICL:
$2.25B
CLBT:
$416.33M
ICL:
$1.35B
CLBT:
$84.98M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
ICL vs. CLBT — Risk / Return Rank
ICL
CLBT
ICL vs. CLBT - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for ICL Group Ltd (ICL) and Cellebrite DI Ltd. (CLBT). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| ICL | CLBT | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | 0.00 | ||
| Sortino ratioReturn per unit of downside risk | -0.03 | ||
| Omega ratioGain probability vs. loss probability | 0.97 | 0.97 | -0.01 |
| Calmar ratioReturn relative to maximum drawdown | -0.41 | -0.43 | +0.02 |
| Martin ratioReturn relative to average drawdown | -0.68 | -0.95 | +0.27 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| ICL | CLBT | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | -0.36 | -0.36 | 0.00 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.00 | — | — |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.26 | — | — |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.09 | 0.12 | -0.02 |
Drawdowns
ICL vs. CLBT - Drawdown Comparison
The maximum ICL drawdown since its inception was -63.87%, smaller than the maximum CLBT drawdown of -67.74%. Use the drawdown chart below to compare losses from any high point for ICL and CLBT.
Loading charts...
Drawdown Indicators
| ICL | CLBT | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -63.87% | -67.74% | +3.87% |
Max Drawdown (1Y)Largest decline over 1 year | -33.77% | -43.61% | +9.84% |
Max Drawdown (3Y)Largest decline over 3 years | -40.93% | -57.58% | +16.65% |
Max Drawdown (5Y)Largest decline over 5 years | -63.87% | — | — |
Max Drawdown (10Y)Largest decline over 10 years | -63.87% | — | — |
Current DrawdownCurrent decline from peak | -43.52% | -48.35% | +4.83% |
Average DrawdownAverage peak-to-trough decline | -30.37% | -34.51% | +4.14% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 20.33% | 19.76% | +0.57% |
Volatility
ICL vs. CLBT - Volatility Comparison
The current volatility for ICL Group Ltd (ICL) is 13.68%, while Cellebrite DI Ltd. (CLBT) has a volatility of 21.22%. This indicates that ICL experiences smaller price fluctuations and is considered to be less risky than CLBT based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| ICL | CLBT | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 13.68% | 21.22% | -7.54% |
Volatility (6M)Calculated over the trailing 6-month period | 26.72% | 40.11% | -13.39% |
Volatility (1Y)Calculated over the trailing 1-year period | 38.27% | 51.76% | -13.49% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 37.25% | 50.35% | -13.10% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 34.73% | 50.35% | -15.62% |
Dividends
ICL vs. CLBT - Dividend Comparison
ICL's dividend yield for the trailing twelve months is around 2.64%, while CLBT has not paid dividends to shareholders.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
CLBT Cellebrite DI Ltd. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
ICL ICL Group Ltd | 2.64% | 2.29% | 3.96% | 7.34% | 16.15% | 2.58% | 1.82% | 4.45% | 6.65% | 7.23% | 4.23% | 6.73% |
Financials
ICL vs. CLBT - Financials Comparison
This section allows you to compare key financial metrics between ICL Group Ltd and Cellebrite DI Ltd.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
ICL vs. CLBT - Profitability Comparison
ICL - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, ICL Group Ltd reported a gross profit of 626.00M and revenue of 2.02B. Therefore, the gross margin over that period was 30.9%.
CLBT - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Cellebrite DI Ltd. reported a gross profit of 105.88M and revenue of 128.30M. Therefore, the gross margin over that period was 82.5%.
ICL - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, ICL Group Ltd reported an operating income of 234.00M and revenue of 2.02B, resulting in an operating margin of 11.6%.
CLBT - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Cellebrite DI Ltd. reported an operating income of 9.23M and revenue of 128.30M, resulting in an operating margin of 7.2%.
ICL - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, ICL Group Ltd reported a net income of 126.00M and revenue of 2.02B, resulting in a net margin of 6.2%.
CLBT - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Cellebrite DI Ltd. reported a net income of 10.94M and revenue of 128.30M, resulting in a net margin of 8.5%.
Frequently Asked Questions
ICL and CLBT have a correlation of 0.15, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
CLBT has higher volatility (21.22%) compared to ICL (13.68%). In terms of maximum drawdown, ICL dropped -63.87% vs CLBT's -67.74%.
ICL currently has the higher Sharpe Ratio (-0.36 vs -0.36), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for ICL and CLBT
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer